| Catalog No. |
Size |
Price |
Figures |
|---|
Z00025-1 mg
| 1 mg | $ 420.00 |
References:
- Haro I, et al. Liposome entrapment and immunogenic studies of a synthetic lipophilic multiple antigenic peptide bearing VP1 and VP3 domains of the hepatitis A virus: a robust method for vaccine design. FEBS Lett. Apr 2003; 540(1-3): 133-140.
- Costa-Mattioli M, et al. Molecular evolution of hepatitis A virus: a new classification based on the complete VP1 protein. J. Virol. Sep 2002; 76(18): 9516-9525.
- Graff J, et al. Hepatitis A virus capsid protein VP1 has a heterogeneous C terminus. J. Virol. Jul 1999; 73(7): 6015-6023.
|
|---|
| Full Name | | Hepatitis A Virus (HAV) VP1 |
|
| Abbreviated Name-1 | HAV-VP1; Hepatitis A Virus-VP1 |
|---|
| Description | Hepatitis A Virus (HAV) VP1 is an E. coli-derived recombinant. The protein Hepatitis A Virus (HAV) VP1 contains the HAV VP1 immunodominant regions, amino acids: 524-633. |
|---|
| Source | E. coli |
|---|
| M.W. | 33,000 Da |
|---|
| Purity | Protein is >90% pure as determined by 10% PAGE (coomassie staining). |
|---|
| Storage | Protein is shipped at ambient temperature. Upon arrival, store at -20°C. |
|---|
| Concentration | 1 mg/ml in 10 mM CBB, pH 9.6, 0.1% SDS, 50% glycerol |
|---|
| Stability | Five years frozen. one month in solution at room temperature. |
|---|
| Specificity | Immunoreactive with sera of HAV-infected individuals |
|---|
| Applications | Antigen in ELISA and Western blots, excellent antigen for detection of HAV with minimal specificity problems |
|---|
